Preferred Label : biological therapy;
MeSH definition : Treatment of diseases with biological materials or biological response modifiers,
such as the use of GENES; CELLS; TISSUES; organs; SERUM; VACCINES; and humoral agents.;
MeSH synonym : therapy, biological; biological therapies; biologic therapy; therapy, biologic; therapies, biological; biologic therapies; therapies, biologic; biotherapy; biotherapies;
MeSH annotation : general or unspecified; prefer specifics;
Wikipedia link : https://en.wikipedia.org/wiki/Biotherapy;
Origin ID : D001691;
UMLS CUI : C0005527;
Allowable qualifiers
Automatic exact mappings (from CISMeF team)
Record concept(s)
See also (suggested by CISMeF)
Semantic type(s)
UMLS correspondences (same concept)
Treatment of diseases with biological materials or biological response modifiers,
such as the use of GENES; CELLS; TISSUES; organs; SERUM; VACCINES; and humoral agents.
https://www.has-sante.fr/jcms/p_3539093/fr/stelara-ustekinumab-biotherapies-par-voie-sous-cutanee-dans-les-maladies-inflammatoires-chroniques
2024
false
false
false
France
drug prescriptions
evaluation of the transparency committee
injections, subcutaneous
Ustekinumab
chronic disease
biological therapy
---
https://www.has-sante.fr/jcms/p_3539144/fr/kevzara-sarilumab-biotherapies-par-voie-sous-cutanee-dans-les-maladies-inflammatoires-chroniques
2024
false
false
false
France
drug prescriptions
evaluation of the transparency committee
chronic disease
injections, subcutaneous
sarilumab
biological therapy
---
https://www.has-sante.fr/jcms/p_3539099/fr/cinqaero-reslizumab-biotherapies-par-voie-sous-cutanee-dans-les-maladies-inflammatoires-chroniques
2024
false
false
false
France
drug prescriptions
evaluation of the transparency committee
reslizumab
chronic disease
biological therapy
---
https://www.has-sante.fr/jcms/p_3539102/fr/xolair-omalizumab-biotherapies-par-voie-sous-cutanee-dans-les-maladies-inflammatoires-chroniques
2024
false
false
false
France
drug prescriptions
evaluation of the transparency committee
Omalizumab
injections, subcutaneous
biological therapy
chronic disease
---
https://www.has-sante.fr/jcms/p_3539105/fr/enbrel-etanercept-biotherapies-par-voie-sous-cutanee-dans-les-maladies-inflammatoires-chroniques
2024
false
false
false
France
drug prescriptions
-
evaluation of the transparency committee
injections, subcutaneous
biological therapy
Etanercept
chronic disease
---
https://www.has-sante.fr/jcms/p_3539075/fr/orencia-abatacept-biotherapies-par-voie-sous-cutanee-dans-les-maladies-inflammatoires-chroniques
2024
false
false
false
France
drug prescriptions
evaluation of the transparency committee
biological therapy
injections, subcutaneous
Abatacept
chronic disease
---
https://www.has-sante.fr/jcms/p_3539096/fr/kyntheum-brodalumab-biotherapies-par-voie-sous-cutanee-dans-les-maladies-inflammatoires-chroniques
2024
false
false
false
France
drug prescriptions
evaluation of the transparency committee
biological therapy
chronic disease
brodalumab
injections, subcutaneous
---
https://www.has-sante.fr/jcms/p_3539138/fr/taltz-ixekizumab-biotherapies-par-voie-sous-cutanee-dans-les-maladies-inflammatoires-chroniques
2024
false
false
false
France
drug prescriptions
evaluation of the transparency committee
chronic disease
ixekizumab
biological therapy
injections, subcutaneous
---
https://www.has-sante.fr/jcms/p_3539126/fr/dupixent-dupilumab-biotherapies-par-voie-sous-cutanee-dans-les-maladies-inflammatoires-chroniques
2024
false
false
false
France
drug prescriptions
evaluation of the transparency committee
chronic disease
biological therapy
dupilumab
injections, subcutaneous
---
https://www.has-sante.fr/jcms/p_3539111/fr/humira-adalimumab-biotherapies-par-voie-sous-cutanee-dans-les-maladies-inflammatoires-chroniques
2024
false
false
false
France
drug prescriptions
evaluation of the transparency committee
chronic disease
biological therapy
adalimumab
Adalimumab
injections, subcutaneous
---
https://www.has-sante.fr/jcms/p_3539117/fr/fasenra-benralizumab-biotherapies-par-voie-sous-cutanee-dans-les-maladies-inflammatoires-chroniques
2024
false
false
false
France
drug prescriptions
evaluation of the transparency committee
injections, subcutaneous
benralizumab
chronic disease
biological therapy
---
https://www.has-sante.fr/jcms/p_3539141/fr/simponi-golimumab-biotherapies-par-voie-sous-cutanee-dans-les-maladies-inflammatoires-chroniques
2024
false
false
false
France
drug prescriptions
evaluation of the transparency committee
chronic disease
biological therapy
golimumab
injections, subcutaneous
---
https://www.has-sante.fr/jcms/p_3539084/fr/tremfya-guselkumab-biotherapies-par-voie-sous-cutanee-dans-les-maladies-inflammatoires-chroniques
2024
false
false
false
France
drug prescriptions
evaluation of the transparency committee
injections, subcutaneous
guselkumab
biological therapy
chronic disease
---
https://www.has-sante.fr/jcms/p_3539114/fr/cimzia-certolizumab-pegol-biotherapies-par-voie-sous-cutanee-dans-les-maladies-inflammatoires-chroniques
2024
false
false
false
France
drug prescriptions
evaluation of the transparency committee
biological therapy
injections, subcutaneous
Certolizumab Pegol
chronic disease
---
https://www.has-sante.fr/jcms/p_3539129/fr/kineret-anakinra-biotherapies-par-voie-sous-cutanee-dans-les-maladies-inflammatoires-chroniques
2024
false
false
false
France
drug prescriptions
anakinra
evaluation of the transparency committee
interleukin 1 receptor antagonist protein
injections, subcutaneous
biological therapy
chronic disease
---
https://www.has-sante.fr/jcms/p_3539135/fr/roactemra-tocilizumab-biotherapies-par-voie-sous-cutanee-dans-les-maladies-inflammatoires-chroniques
2024
false
false
false
France
drug prescriptions
evaluation of the transparency committee
injections, subcutaneous
biological therapy
tocilizumab
chronic disease
---
https://www.has-sante.fr/jcms/p_3539069/fr/ilaris-canakinumab-biotherapies-par-voie-sous-cutanee-dans-les-maladies-inflammatoires-chroniques
2024
false
false
false
France
drug prescriptions
evaluation of the transparency committee
canakinumab
injections, subcutaneous
chronic disease
biological therapy
---
https://www.has-sante.fr/jcms/p_3539147/fr/nucala-mepolizumab-biotherapies-par-voie-sous-cutanee-dans-les-maladies-inflammatoires-chroniques
2024
false
false
false
France
drug prescriptions
evaluation of the transparency committee
biological therapy
mepolizumab
chronic disease
injections, subcutaneous
---
https://www.has-sante.fr/jcms/p_3539072/fr/cosentyx-secukinumab-biotherapies-par-voie-sous-cutanee-dans-les-maladies-inflammatoires-chroniques
2024
false
false
false
France
drug prescriptions
evaluation of the transparency committee
injections, subcutaneous
biological therapy
secukinumab
chronic disease
---
https://www.has-sante.fr/jcms/p_3269932/fr/reeducation-de-l-appareil-locomoteur-dans-les-pathologies-neuro-musculaires-suite-a-l-introduction-de-nouvelles-technologies-biotherapie-instrumentation-rachidienne-reentrainement-a-l-effort-note-de-cadrage
2024
false
false
false
France
practice guideline
news
Pathology
Technology
instrumentalist
neurology
Disorders
technology
Pathology
Pathology
rehabilitation therapy, nos
biological therapy
musculoskeletal system
muscle, nos
physical exertion
device, nos
Pathology
vertebral column, nos
instrument, nos
Pathology
exertion, nos
muscular diseases
Pathology
myofunctional therapy
Pathology
---
https://www.has-sante.fr/jcms/p_3539090/fr/remsima-infliximab-biotherapies-par-voie-sous-cutanee-dans-les-maladies-inflammatoires-chroniques
2024
false
false
false
France
drug prescriptions
evaluation of the transparency committee
Infliximab
injections, subcutaneous
chronic disease
biological therapy
---
https://ansm.sante.fr/actualites/modification-des-conditions-de-prescription-et-de-delivrance-de-certaines-biotherapies-utilisees-dans-le-traitement-de-maladies-inflammatoires-chroniques
2024
false
false
false
France
French
guidelines for drug use
injections, subcutaneous
Interleukin Inhibitors
immunosuppressive agents
biological therapy
general practice
antibodies, monoclonal
immunoconjugates
Tumor Necrosis Factor Inhibitors
Chronic inflammatory disorder (disorder)
---
https://www.inesss.qc.ca/publications/repertoire-des-publications/publication/infection-a-helicobacter-pylori.html
2024
Canada
technical report
Diagnosis Code
laboratory diagnosis
Medically Treated Reflux
helicobacter pylori
biology
infectious disease, nos
Biological Agent
Diagnosis Study
Analysis
continuity of patient care
Follow
Analyzed
Clinical Study Follow-up
helicobacter infections
Helicobacter Pylori Infection
Date of Diagnosis
Biotechnology
helicobacter pylori
laboratory diagnosis
clinical laboratory techniques
Use
biological therapy
---
https://www.has-sante.fr/jcms/p_3539087/fr/adtralza-tralokinumab-maladies-inflammatoires-chroniques
2024
false
false
false
France
biological therapy
drug prescriptions
tralokinumab
evaluation of the transparency committee
administration, cutaneous
tralokinumab
---
https://www.has-sante.fr/jcms/p_3539120/fr/bimzelx-bimekizumab-biotherapies-par-voie-sous-cutanee-dans-les-maladies-inflammatoires-chroniques
2024
false
false
false
France
drug prescriptions
evaluation of the transparency committee
bimekizumab
chronic disease
biological therapy
injections, subcutaneous
---
https://www.has-sante.fr/jcms/p_3539108/fr/skyrizi-risankizumab-biotherapies-par-voie-sous-cutanee-dans-les-maladies-inflammatoires-chroniques
2024
false
false
false
France
drug prescriptions
evaluation of the transparency committee
risankizumab
chronic disease
injections, subcutaneous
biological therapy
---
https://www.has-sante.fr/jcms/p_3539132/fr/ilumetri-tildrakizumab-biotherapies-par-voie-sous-cutanee-dans-les-maladies-inflammatoires-chroniques
2024
false
false
false
France
drug prescriptions
evaluation of the transparency committee
biological therapy
injections, subcutaneous
chronic disease
tildrakizumab
---
https://www.has-sante.fr/jcms/p_3539123/fr/tezspire-tezepelumab-biotherapies-par-voie-sous-cutanee-dans-les-maladies-inflammatoires-chroniques
2024
false
false
false
France
drug prescriptions
evaluation of the transparency committee
injections, subcutaneous
chronic disease
tezepelumab
biological therapy
---
https://www.has-sante.fr/jcms/p_3539081/fr/omvoh-mirikizumab-biotherapies-par-voie-sous-cutanee-dans-les-maladies-inflammatoires-chroniques
2024
false
false
false
France
drug prescriptions
evaluation of the transparency committee
chronic disease
mirikizumab
injections, subcutaneous
biological therapy
---
https://www.ameli.fr/assure/sante/themes/biotherapies
2022
France
popular works
biological therapy
---
http://www.lecofer.org/item-objectifs-0-22-0.php
2021
France
educational course
biological therapy
Amnesia
therapy, nos
---
https://www.inesss.qc.ca/covid-19/traitements-specifiques-a-la-covid-19/biotherapies-ciblant-la-voie-de-linterleukine-1.html
2020
false
false
false
Canada
pneumonia, viral
coronavirus infections
Interleukin-1
anakinra
canakinumab
guideline
biological therapy
interleukin 1 receptor antagonist protein
pandemics
pneumonia, viral
coronavirus infections
pandemics
antibodies, monoclonal
COVID-19
---
https://www.getaid.org/wp-content/uploads/2020/03/InformationISCovid10mars.pdf
2020
France
coronavirus infections
COVID-19
popular works
azathioprine
rheumatology
disease
adrenal cortical hormone, nos
glucocorticoids
methotrexate
Diseases
Janus Kinase Inhibitors
intestinal diseases
Dermatology
Dermatologists
disease, nos
disease of intestine, nos
methotrexate
dermatology
immunosuppressive agents
azathioprine
biological therapy
corticosteroid therapy
Dermatology
disease
pneumonia, viral
COVID-19
---
https://hiboot.larhumatologie.fr/
https://apps.apple.com/fr/app/hiboot/id1188410178?mt=8
https://play.google.com/store/apps/details?id=com.hiboot
2019
false
true
false
false
France
French
mobile application
methotrexate
biological therapy
mobile applications
rheumatic fever
---
https://www.louvainmedical.be/fr/article/les-biotherapies-dans-le-traitement-du-psoriasis-modere-severe
2019
false
false
false
Belgium
biological therapy
psoriasis
antibodies, monoclonal
apremilast
biological therapy
continuity of patient care
journal article
thalidomide
thalidomide
---
Targeted therapies in inflammatory skin diseases
http://www.academie-medecine.fr/therapeutiques-ciblees-dans-les-maladies-inflammatoires-cutanees/
2019
false
false
false
France
psoriasis
dermatitis, atopic
biological therapy
journal article
---
http://www.academie-medecine.fr/cibles-des-biotherapies-au-cours-des-maladies-inflammatoires/
2018
false
false
false
France
tumor necrosis factor-alpha
arthritis, rheumatoid
psoriasis
arthritis, psoriatic
crohn disease
spondylitis, ankylosing
Interleukin-6
Interleukin-17
lymphocytes
journal article
biological therapy
Tumor Necrosis Factor Inhibitors
---
http://www.academie-medecine.fr/traitements-biologiques-des-rhumatismes-inflammatoires-chroniques-resultats-cliniques/
2018
false
false
false
France
arthritis, rheumatoid
spondylarthropathies
arthritis, psoriatic
treatment outcome
antirheumatic agents
biosimilar pharmaceuticals
biological products
journal article
biological therapy
chronic disease
---
http://www.lecofer.org/item-objectifs-0-24-6.php
2017
true
true
false
false
France
French
educational course
French pre-residency program examination
rheumatology
biological therapy
biological therapy
biological therapy
biological therapy
rheumatic fever
general practitioners
---
https://www.revmed.ch/RMS/2017/RMS-N-553/Effets-secondaires-des-traitements-biologiques
2017
false
false
false
Switzerland
French
journal article
biological therapy
Inflammatory joint disease
Infliximab
antirheumatic agents
gastrointestinal agents
Etanercept
Adalimumab
Certolizumab Pegol
golimumab
Drug-Related side effects and adverse reactions
Infection reactivation
Reinfection tuberculosis (disorder)
Reactivation of hepatitis B viral hepatitis (disorder)
Reactivation of hepatitis C viral hepatitis (disorder)
leukoencephalopathy, progressive multifocal
lymphoproliferative disorders
cardiovascular diseases
Liver function tests outside reference range (finding)
hypercholesterolemia
leukopenia
hypogammaglobulinemia
antibodies, antinuclear
Injection related reaction
Injection site reaction
drug eruptions
Drug-induced pneumonitis (disorder)
tumor necrosis factors
opportunistic infections
agammaglobulinemia
antibodies, monoclonal
Tumor Necrosis Factor Inhibitors
---
http://www.sudoc.fr/221402373
2017
false
true
false
France
French
dissertations, academic
biological therapy
patients
rheumatic diseases
---
https://assurance-maladie.ameli.fr/etudes-et-donnees/2016-biotherapies-mici
2016
France
technical report
chronically ill
chronic disease
biological therapy
chronic disease, nos
inflammatory bowel disease, nos
inflammatory bowel diseases
Chronic disease
Diseases
Inflammatory disease
---
http://archives.uness.fr/sites/umvf/media/ressRhumatologie/2016-abrege/2016-Chapitre23.pdf
2016
false
false
true
France
French
educational course
biological therapy
biological therapy
biological therapy
rheumatic fever
rheumatology
biological therapy
---
https://www.has-sante.fr/portail/jcms/c_2580906/fr/evaluation-medico-economique-des-traitements-de-fond-biologiques-dans-la-prise-en-charge-de-la-polyarthrite-rhumatoide
2015
false
false
false
France
economic evaluation
technical report
Cost-Benefit analysis
drug costs
antibodies, monoclonal
antibodies, monoclonal
treatment outcome
tumor necrosis factor-alpha
methotrexate
Leflunomide
sulfasalazine
hydroxychloroquine
biosimilar pharmaceuticals
Etanercept
Adalimumab
Infliximab
Certolizumab Pegol
golimumab
Abatacept
Rituximab
tocilizumab
sarilumab
anakinra
practice guidelines as topic
biological therapy
arthritis, rheumatoid
interleukin 1 receptor antagonist protein
antibodies, monoclonal, humanized
Tumor Necrosis Factor Inhibitors
---
http://www.revmed.ch/RMS/2015/RMS-N-468/Psoriasis-nouveautes-et-defis-en-2015
2015
false
false
false
France
French
journal article
psoriasis
comorbidity
biological therapy
treatment outcome
---
In In Paediatrica Vol. 26 No. 2 2015
https://www.paediatrieschweiz.ch/fr/nouveaux-traitements-en-rhumatologie-pediatrique-les-medicaments-biologiques/
2015
false
false
false
Switzerland
French
journal article
child
rheumatic diseases
biological therapy
biological therapy
continuity of patient care
immunosuppressive agents
antirheumatic agents
immunosuppressive agents
immunosuppressants
Infections
arthritis, juvenile
chronic Inflammatory rheumatism
socioeconomic factors
---
http://www.sciencedirect.com/science/article/pii/S024886631400589X
http://dx.doi.org/10.1016/j.revmed.2014.07.008
2015
false
false
false
France
French
uveitis
journal article
biological therapy
tumor necrosis factor-alpha
Behcet syndrome
immunoglobulins, intravenous
rituximab
infliximab
adalimumab
treatment outcome
anakinra
anakinra
interleukin 1 receptor antagonist protein
interferon alfa-2a
tocilizumab
tocilizumab
Adalimumab
Infliximab
Rituximab
antibodies, monoclonal, humanized
chorioretinitis
antibodies, monoclonal, Murine-Derived
recombinant proteins
interferon-alpha
Interferon alpha-2
Tumor Necrosis Factor Inhibitors
---
http://www.institut-biotherapies.fr/
France
French
rare diseases
biomedical research
research structure
biological therapy
---
http://www.atlanpolebiotherapies.com/
France
French
competitive behavior
biological therapy
association
organizations
---
https://www.legifrance.gouv.fr/jo_pdf.do?id=JORFTEXT000019494693
2008
false
France
French
cell- and Tissue-Based therapy
biological therapy
genetic therapy
legislation as topic
legislation
---
https://www.amub-ulb.be/system/files/rmb/old/408
2008
Belgium
French
biological therapy
biological products
psoriasis
journal article
---
https://www.therapeutique-dermatologique.org/spip.php?article1349
2008
France
French
biological therapy
dermatology
antineoplastic agents
scientific and technical information
---
http://www.senat.fr/noticerap/2008/r08-079-notice.html
http://www.senat.fr/rap/r08-079/r08-079_mono.html
2008
France
French
cordocentesis
fetal blood
fetal stem cells
adult stem cells
biological therapy
technical report
---
http://www.john-libbey-eurotext.fr/fr/revues/bio_rech/jpc/e-docs/00/04/08/47/resume.md?type=text.html
2004
France
French
English
biological therapy
patient satisfaction
musculoskeletal diseases
antirheumatic agents
france
health surveys
biological therapy
treatment outcome
antibodies, monoclonal
Bias
immunoglobulin G
receptors, tumor necrosis factor
sialoglycoproteins
journal article
french abstract
questionnaires
---